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The correlation between high cholesterol concentrations in human blood and the 
risk for coronary heart disease has prompted a national effort to identify and treat all 
American adults who are at high risk because of elevated cholesterol levels. This effort has 
been very successful in increasing the awareness of the public about the importance of 
monitoring cholesterol levels. For this awareness· to be truly beneficial requires that precise 
and accurate cholesterol measurement ~ethoqs be. us,ed to identify those individuals at risk. 
At present, the reliability of serum cholesterol measurements in the United States points to 
the need for more accurate testing methods. The need for more accurate methods for 
determining cholesterol especially in associatiol). with the various lipoproteins has led to the 
development of a new method in which cholesterol levels are determined using cir<;ular · 
dichroism spectropolarimetry. 
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The national ~ffort to educate the general public about the increased risks of 
coronary heart disease (CHD) and artherosclerosis due to increased accumulation of arterial 
plaque caused by eleyated serum cholesterol levels has been very successful. The public is 
now encouraged to know their cholesterol levels and cautioned that an uncontrolled diet 
and lack of exercise, as well as other factors such as age, gender, heredity, tobacco use and 
alcohol consumption can increase the risk of CHD (1,2). This has led to the necessity for 
automated methods for cholesterol determinations to handle the immensity of the screening 
program required. Cholesterol screening is now being done everywhere from shopping 
malls, supermarkets and other high traffic puplic areas to the more traditional hospital and 
laboratory settings. The methods used differ in complexity from the simple dip-stick 
' ' 
method where a color sensitive reaction is. measured on a paper support to more 
sophisticated lipid profile tests which determine the distribution of cholesterol among the 
three solubilizing macromolecules (3). The dip-stick me~od is used as a preliminary 
qualitative test to determine ~e need for a fuller more quantit:3:tive measurement. 
A report (4) was prepared by the Laboratory Standardization Panel (LSP) of the 
National Cholesterol ~ducation Program (NCEP) at the conclusion of a recent study of the 
relationship of health risk factors with elevated serum choles~erol levels. This study 
correlated the risk with three ranges of total cholesterol (TC). An individual was 
considered to be at: low risk if the TC was in the desirable concentration range of less than 
200mg/dL; marginal risk in the borderline high range from 200-239mg/dL; and high risk 
for concentrations of 240mg/dL and greater. Individuals are judged to belong to_ one or 
1 
2 
another of these risk categories based on the results of a serum TC measurement, then the 
other risk factors (1,2) are added and evaluated as a basis for patient counselling. Previous 
criteria for evaluating an individual's. relative risk involved using a TC to high-density 
' ' 
lipoprotein cholesterol (HDL-C) ratio (1,5). Low relative risk was indicated by a TC to 
HDL-C ratio of less than 5 and implied a high level of HDL-C. The HDL-C was measured 
in a second independent test for this evaluation method. 
The report prepared by LSP (4) also described serious inaccuracies in measurement 
of the concentration of TC present in human serum reference standards, made by many 
clinical laboratories in their determinations. A 1985 survey, by the College of American 
Pathologists (CAP), in which results from 5,004 participating laboratories were submitted 
was cited to point out these inaccuracies. T~e results from laboratories using an enzymatic 
method were found to have 47% of their values to differ more than ±5% of the Centers for 
Disease Control (CDC) Confirmatory Value even after the ,values greater than 3 standard 
deviations from the mean value were removed. Of the 47%, about 16% were equal to or 
greater than ±10% and 8% were equal to or greater than ±15% of the CDC value. This 
prompted the recommendation by the LSP that the co~fficient ·of variation (CV) be 
improved to within ±3% for TC by 1992: Although the results of similar surveys by the 
CAP in 1986 and 1987 were much tlie same as in 1985, more recent surveys of certified 
laboratories show that much progress is being made towards meeting the recommendations 
of the LSP using the current clinical methods and instrumentation (6). Ina.Ccuracies in the 
determination of the distribution of cholesterol among the various lipoproteins were not 
reported by the LSP, but future evaluation was indicated. Important correlations between 
HDL-C levels and CHD are recognized but universal measurement of HDL-C is not 
recommended at this time because the current technology lacks the necessary reliability and 
proficiency (5, 7 ,8). Interlaboratory CV's as high as 38% were reported in a recent 
publication (7). A 1987 CAP survey in which over two thousand laboratories analyzed the 
same sample for HDL-C showed a more than 5% difference from the reference value was 
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reported by more than one third of these laboratories. The inaccuracies in the current 
methods of determining HDL-C indicate that they lack predictive clinical value. 
In the serum, cholesterol is distributed in association with high-density lipoproteins 
(HDL), low-density lipoproteins (LDL) and, with triglycerid~s as the yery low-density 
'· 
lipoproteins (VLDL). Statistical evidence from several long term clinical tests indicates that 
a high proportion bf HDL-C and ·a low proportion of LDL-C is associated with lower 
relative CHD risk (1,2). This justifies that high levels of LDL-C are to be avoided while 
HDL-C is considered to be beneficial in higHer proportions (5). There has been no direct 
implication of VLDL-C in any risk determination but· high triglyceride can be a serious 
health problem by itself. A typical lipid profile' study consists of the direct measurement of 
' ' 
total and HDL cholesterols and direct measurement of triglyceride. The triglyceride is 
divided by five and this value is taken as the VLDL cholesterol. The VLDL-C and HDL-C 
values are then subtracted from the value for total cholesterol to obtain the LDL-C value. 
This makes the LDL-C the least accurately known fraction due to the .propagation of any 
errors in the measurement of the other three fractions. This makes it difficult to monitor 
clinical progress in LDL-C reduction therapy with accuracy. 
The goal of this research project was to. develop a method for cholesterol screening 
which would allow HDL-C, VLDL~C and espedally LDL-C to be determined directly in a 
single experiment. The ·selectivity of CD detection is such that this goal is not 
unreasonable, if the method of detection is coupled with an appropriate color-inducing 
reaction. A critical part of the research was to select a chemical reaction that would 
introduce, into the cholesterol molecule, a chromophore which absorbs light at a suitable 
wavelength and is situated near a chiral center. Mapy reactions were investigated but only 
the reaction ultimately considered to best meet the reqUirements is diScussed in this report. 
It was also sought to reconfirm the presence of excessive experimental error in 
' ' 
conventional methods of determining HDL-C and further point out the need for new 
methods of testing. To assess the validity of the newly developed procedure, comparisons 
4 
were made between cholesterol lipid distribution data from separate laboratories using 
different methods of determination. 
CHAPTER II 
IDSTORICAL AND THEORETICAL BACKGROUND 
OF CIRCULAR DICHROISM , 
History 
The first recorded observation of op~ical activity was made ~in 1811 by Arago, a 
French astronomer, with the use of quartz plates he was able to rotate the plane of 
polarization of plane-polarized light (9,10). In 1812, Biot demonstrated that polarized light 
could also be rotated by solutions~of some organic compounds (10,11) showing that optical 
activity was not limited to crystalline substances. In independent observations , Biot and 
Fresnel noted that the angle of r<?tation of light by a substance was increased as the 
wavelength of the incident light striking, the substance was decreased (9). This effect is 
known as optical rotatory dispersion (ORD). In 1846 Haidinger observed the unequal 
absorption of left and right circularly polarized light by amethyst quartz crystals (9), 
identifying the phenomena now known as circular dichroism (CD). 
In 1848 Louis Pasteur provided the first insights into the physical basis for optical 
activity. He used the term dissymmetry to describe the mirror image like difference in 
hemihedral crystals of a tartrate (12). In 1860 he explained molecular dissymmetry and the 
dissymmetry caused by the structure of certain crystals because of the molecular 
structure(11). Pasteur was able to physically separate crystals from a racemic mixture of 
sodium ammonium tartrate into it's two enantiomers and make solutions from each of 
these. Each of these solutions was found to rotate an incident beam of polarized light to a 
certain angle but each rotated the~light in a different direction. From his experiments 
5 
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Pasteur concluded that there were 'two categories of molecules: those that are 
superimposable mirror images and those that are nonsuperimposable mirror images (13). 
He concluded that molecules which exhibit optical activity were of the nonsuperimposable 
type (10). 
In 1874 Van't Hoff proposed the existence of assymmetric carbon atoms with a 
tetrahedral configuration (14). This necessitated' the use of three dimensional formulae to 
' > ' 
adequately describe organic, molecules. 
To underStand the physical nature and causes·of optical activity, studies were made 
using chiroptical techniques. In 1896 Aime Cotton frrst discovered CD in solutions of 
copper and chromium tartrates and,used these solutions to investigate both CD and ORO 
(9). His research led him to believe tha~· the curves produced by CD were the result of 
differences in absorbari.ce of rj.ght and left circularly polarized light. 
Theory 
,, 
As defmed by the IUPAC (16) an optically active substance is one which exhibits 
different interactions with left and right circu,larly polarized light· .. One type of optically 
,. ' 
active media is the inherently dissymetJical molecule (9). This Jype of optically active 
' I ' ' 
molecule requires the presence of an assymmetric carbon atom wi~ a chromopliore in close 
proximity. The substances discussed. in this study are of this type,. This interaction with . -- ' \ 
cirCularly polarized light is the basis for the chiropticill techniques .of polarimetry, ORO and . 
CD (17). 
The optical phenomena of' circular dichrOism (CD) and optical rotation are related to 
those for ordinary absorption and dispersion (13)~ Circular dichroism is the term for the 
difference in absorption coefficients of an optically active m~dium for left and right 
circularly polarized light, while circular birefringence is the differeJ!ce in the refractive 
indices of the medium for the circularly polarized components. 
7 
To understand the difference~ in chiroptical and ordinary spectroscopic methods, an 
explanation of the electromagnetic radiation used in them is necessary. The wave 
phenomenon of light is caused by transverse vibr~tions of the electric field vector, Figure 
1. A magnetic field vector is perpendicular to the oscillating electric field vector but can be 
ignored during this discussi~n . The electric field vibration is perpendicular to the direction 
in which the light wave .. travels and occurs ~n an infinite number of planes . · The 
unpolarized monochromatic light used fqr UV visible spectroscopy consists of different 
wavelengths vibrating in many different planes. · 
Figure 2.a is a schematic representation.of unpolarized light. Figure 2.b depicts 
linearly polarized light whi~h vibrates in only one direction. This is the type of light 
utilized in chiroptical techniques. Linearly polarized light can: be considered as the vector 
sum of its left and right circularly polarized-components, Figure 3. Over time, as the wave 
travels along a given axis the ~lectric field vectors of the left and right circularly polarized 
light trace out left and right handed hdice~. If the vectors are not allowed to propagate in 
distance, but only in time, the circular figures depicted in Figure 2.c and d result. 
The incident linearly polarized light use.d to investigat~ optically active absorbing 
samples can be described as having the two circular components in phase with amplitudes 
which are equal but opposite in sign, Figure 3. These two components travel through the 
medium with different speeds due to the crrcular birefringence, T\L - T\R, of the medium. In 
the resultant transmitted wave the two circular components are no longer in phase and have 
unequal angles from the incident plane of polarization (ro '# ro').· The major axis of 
vibration is rotated from that of the incident light by an angle a which is termed the optical 
rotation, Figure 3.b. When linearly polarized light passes through a sample that is not 
optically active the field vectors remain in phase, the angles of each of the two vectors with 
the incident plane are equal (ro = ro'), and the transmitted beam is still linearly polarized in 






Figure 1. Transverse wave representation of the electric field associated with a 
monochromatic light beam. The arrows represent the magnitude of 
the oscillating electric field The distance between cycles is related to 





Figure 2. Polarization of monochromatic light beams: 
a) unpolarized light, b) linearly polarized light, c) 
left circularly polarized light, and d) right circu-
larly polarized light. Direction of propagation is 







\ 0) ro' 
--
(b) 
Direction of the electric field vectors 
emerging from a) an achiral medium and b) a 
chiral medium. P is the original plane of 
polarization, L and R are the left and right 
circularly polarized electric field vectors, 
E is the resultant electric field vector. 
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Fresnel correctly postulated that optical rotation in chiral subatances results from the 
difference in refractive index for the left and right circularly polarized light (9). 
(1) 
Differences in refractive indices account for differences in the velocities of the two 
circularly polarized components traversing the medium. The optical rotation, a, is directly 
proportional to the difference in refractive indices and is given by the. equation 
a= 1800(rtL -rtR)/A.(cm) (2) 
and is expressed in degrees per decimeter. 
To normalize the concentration, making it useful for comparison purposes, the 
quantity [a], the specific rotation, is intrpduced, 
[a]= a/c'b (3) 
. . 
where c' is the concentration in g!cm 3 and b is the pathlength of the cell. 
For comparison of solutions of different materials, the molar rott;ttion, [ <1>], must be 
used, 
[<j>] = [a]M/100 (4) 
where M is the molecular weight in g/mole. Division by 100 keeps the numbers sm811 (15) 
and has no physical meaning. This equation normalizes the optical rotation to molecular 
weight and facilitates comparison on a mole for mole basis. 
12 
As the incident linearly polarized beam passes through an achiral (optically active) 
medium there is also a difference in absorbance experienced by the two components. 
(5) 
The molar absorbance coefficient of a substance is related to the absorbance (A) by the 
Beer-Lambert law: 
A=Ebc (6) 
where c is the concentration in moles/Liter, b is the pathlength of the cell and E has units of 
liters per mole centimeter. The left and right circularly polarized components have different 
molar absorption coefficients. The signed difference is defined by IUPAC (13) as circular 
dichroism (CD). 
(7) 
Most CD instruments measure the differential absorbance, M = AL - AR, which is related 
to the difference in molar absorption coefficients described in equation 7, by equation 8, in 
which c is in moles/liter and b is the pathlength. 
M=iltcb (8) 
As a result of the combined differences in the refractive indices and the absorption 
of the left and right components of the linearly polarized light, the components of the 
transmitted beam, as well as being out of phase, are of unequal magnitude. Because of the 
difference in amplitude of the electric field vectors, depicted as L and R in Figure 4, the 
13 
resultant vector, E, traces out an ellipse and no longer oscillates in a single plane. The 
difference in amplitude of the field vectors combined with the circular birefringence 
produces a transmitted beam which is elliptically polarized and rotated by an angle a from 
the original plane of polarization. Equation 7, however, is only nonzero in areas of an 
absorption band thus the CD is only measureable in these regions (17). Since not all 
absorption bands are associated with a chiral chromophore not all absorption bands exhibit 
CD activity. This allows for greater selectivity in CD. 
The arctangent of the ratio of the minor axis of the ellipse, OA, to the major axis of 
the ellipse, OB, is termed the ellipticity, \jf, as shown in figure 4, and is a characterization 
of the eccentricity of the elliptically polarized light. The equation is as follows: 
tan 'I'= ONOB (9) 
Just as (11L -11R) is small compared to the index of refraction, the difference, (eL- £R), 
between absorption coefficients is small (9). 
This allows 'I' to be quantitatively approximated as 
(10) 
where 'A is the wavelength of the incident radiation. This equation is analogous to the 
equation for the optical rotation since optical rotation is characteristic of circular 
birefringence as ellipticity is characteristic of CD. 
The analogy between the two characteristics canies over and is demonstrated by the 
similarity between the expressions for specific ellipticity, [\jf], and specific rotation [a]. 
The specific rotation, described mathematically, is given as 
[\jf] = \jf/c'b (11) 
p E 
Figure 4. Production of elliptically polarized light in circular 
dichroism. P is the· original direction of polarization, 
L and R are left and right circularly polarized light 
respectively, E is the resulting electric field which is 
now. elliptically polarized. 
14 
15 
where 'If is ellipticity measured in degrees, the concentration, c', is in g/ml and the cell path 
length, b, is measured in em. This quantity is useful for comparing different concentration 
of the same substance. 
For comparisons between different substances with different molecular weights, the 
molar ellipticity, [8], provi~es a mole for mole basis. The molar ellipticity is analogous to 
the molar roatation and is defined as 
[8] = [\j/]M/100 (12) 
with M being the moleculat weight in g/mole. The analogous nature of these two 
equations, 4 and 12, direct comparison between the magnitude ofthe optical rotation and 
i ' > 
the ellipticity for an individmtl molecule is possible on a mole to mole basis. Also by 
analogy, the molar ellipticity is proportional to ~E, the difference in the absorption 
coefficients: 
[8] = 3300~E (13) 
where the numerical constant is the result of conversion factors and constants. 
The term ellipticity is still used even though most of the CD spectropolarimeters 
c 
available measure the absorbance difference instead of the ellipticity. Because it is a 
measure of the absorbance difference the Beer-Lambert Law applies and the measurement 
of CD data done in this lab utilizes a definition of the molar ellipticity, 8M, that is similar 
to this law. 
8M = '1'/cb (14) 
16 
The ellipticity, 'If, is measured in degrees, cis the concentration in moles/Land b, the cell 
path length, is measured in em. This choice of units leads to values much different than 
those reported in the literature, but more readily facilitate the quantification of data. 
The spectra obtained from CD measurements differ distintly from those obtained using 
ORD. In a typical ORD sp!!ctrum for a substance without a chi-omophore the ORD curve 
will either rise or fall monotonically, with decreases in wavelength, corresponding to the 
change in the magnitude of the optical rotation. Since these curves usually contain no 
inflection points or cha~ges in sign they are, referred to as plain ORD curves, Figure S.a. 
In molecules which possess an optically active chrom9phore the optical rotation increases 
rapidly as the absorption maximum wavelength of radiation is approached then, just before 
the absorbance maximum is reached, the magnitude decreases drastically, passing through 
zero rotation, until it reaches a minimum from which it increases at a slower rate. The 
resulting curve is a sigmoidal shaped curve rising out of a plain ORD curve as depicted in 
Figure S.b. This type of curve is termed an anomalous ORD curve. Background rotation 
is one of the major drawbacks of ORD making ,it difficult to establish the baseline. Since 
Ae is significant only at wavelengths corresponding to an optically active absorption band 
background rotation is not a problem in CD., The CD spectrum may possess a shape 
similar to the corresponding absorption curve and maxima in both are often close. The 
anomalous peak and trough of the ORD curve corresponds to a single positive or negative 
maximum in the CD curve as shown in Figure S.c. These two different ch~acterizations 





Figure 5. Typical chiroptical spectra: (a) plain ORD curves, (b) anomalous ORD curve with a 
single Cotton effect, and (c) CD curve with a single positive Cotton effect. 
CHAPTER III 
INSTRUMENT ATA TION 
INTRODUCTION 
All CD and UV spectra made in this laboratory were measured by a model J-500A 
automatic recording spectropolarimeter produced by Japan Spectroscopic Co., Ltd. 
(JASCO). A 450 watt xenon arc lamp is the light source for this instrument. The lamp is 
water cooled and is operated in a nitogen purged atmosphere so that ozone produced by the 
lamp does not damage the optical system. Initially the JASCO DP-500 data processor was 
used for data acquisition. CD spectra we1;e recorded on a chart recorder and measurement 
of signal heights was done manually. Acquisition of a JASCO model IF-500-2 interface 
which allowed the J-500A to be coupled to an IBM-AT computer clone allowed the 
replacement of the data processor. The computer then measured CD signals digitally and 
the spectra were printed on a Hewlett-Packard 7475A graphics plotter. 
The instrument was calibrated daily with a 0.025% (WN) solution of androsterone 
in dioxane as suggested by JASCO (18). Instrqment para,meters such as the number of 
scans to be signal averaged and the sensitivity were adjusted to provide spectra quality in 
the minimum necessary time. 
Description of the J-500A Optical System 
CD spectropolarimetry requires a more complex optical system than conventional 
UV -visible spectrophotometry although the two systems are very similar. CD 
18 
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measurements require monochromatic circularly polarized light in contrast to the simple 
monochromatic light necessary for ordinary spectrophotometric measurements. 
A schematic representation of the J-500A optical system is shown in Figure 6. The 
light beam is focused on the entrance slit, S1, by a spherical mirror, Ml. A double 
monochromator is an essential component of the J500A design because of the importance 
of keeping stray radiation to a minimum. S 1 marks the entrance to the first monchrometer 
while the entrance to the second is marked by S2. 
Prisms P1 and P2 are made of crystal quartz and their axial directions differ in 
respect to each other. "This design .allows them to serve the dual purposes of dispersion 
elements and bifefringence polarizers. The light beam emerging from P2 is monochromatic 
and linearly polarized. Lens L focuses this beam onto filter F to filter any remaining 
unpolarized light. The circularly polarized light is produced by the electro-optic modulator 
designated as EOM. The J-500A utilizes a Pockels cell as the EOM. When an electric field 
is applied to the Pockels cell crystal a change in the refractive index and propagation 
velocity for the ordinary and extaordinary beams. These be~s while linearly polarized 
and perpendicular to each other are out of phase. A phase difference of a quarter 
wavelength (1t /2), or any uneven number of quarter wavelengths, produces a circularly 
polarized light beam. The Pockels cell alternately produ.ces left and right circularly 
polarized light by changing the direction of the electric field which changes the direction of 
polarization. This is done at a frequency of 50 kHz. Once the light beams have traversed 






MO, Ml, M2, .M3, M4, ~: spherical mirrors 
LS: ~ight source 
. S 1, S2, S3: slits 
Pl: first prism (horizontal axis) 
P2: second prism (vertical axis) 
L: lens 
F: filter 
EOM: electro-optical modulator (Pockel~ cell) · 
SC:' sample cell 
PMT: photomultiplier tube 
Figure 6. Optical system fqr the J-500A spectrppolarimeter 





INDEPENDENT LABORATORY METHODS 
For this study cholesterol concentration deterniinatioris were made using three 
separate methods. Independent laboratorie~.condu~ting broad range cholesterol screening 
programs provided the data for two conventional commercial methods. The Abbott 
Vision© clinical autoanalyzer, which will be designated as (A), was used by one 
laboratory. The DuPont aca© autoanalyzer, designated as (b), was used by the other 
laboratory. HDL-C concentrations wer~ measured. The Trinder reaction, a double 
enzymatic multistep reaction process which produces a red form of a quinoneimine dye 
(18), is the basis of both commercial processes'.used. The enzymatic reactions involved in 
this process are as follows: 
Cholesterol . 
Cholesterol Esters + H20 Esterase ~ Cholesterol + Fatty ~c1ds 
Cholesterol . 
Cholesterol+ 02 Oxidase > Cholest-4-en-3-one + H202 
2H202 + 4-Aminoantipynne + p-Hydoxybenzenesulfonate Peroxidase> 
Quinoneimine Dye + 4H2.0 
21 
22 
UV-visible absorbance is the method of detection for these determinations. The absorbance 
intensity of the colored end product is proportional to the amount of cholesterol in the 
sample, although the quinoneimine dye is not structurally related to cholesterol. For the 
HDL-C detenninations the same processes were used after the low density lipoprotein 
(LDL) and very low density lipoprotein (VLPL) cholesterol fractions had undergone a 
selective precipitation reaction with a prepared aliquot of dextran sulfate-Mg. Absorbance 
measurements at a single wavelength were made for 538 samples in the (A) data set and 
130 samples in the (D) group.The data from these laboratories we~ collected overextended 
periods of time, up to two years for the laboratory using. method (A). Triglyceride levels 
were measured for only 270 samples, but the values from these can be considered 
representative of the whole. . TC and. HDL-C were measured only once by these 
laboratories before they released the serum samples to our laboratory. The serum layer was 
removed and stored at 0-5~C upon receipt ohhe sample. 
CD Detection Method 
The experimental procedure used to obtain the third set of data was developed in the 
laboratory of Dr. Neil Purdie in th~ chemistry department of Oklahoma State University, 
and is the basis of a patent application filed with the US Patent Office, January 1990. The 
reaction is totally a nonenzymatic chromogenic reaction attributed to Chugaev (19) and the 
method of detection is full spectrum circular dichroism (CD) spectropolarimetry (20), as 
opposed to simple absorbance. The reagent is a two to one mixture of 20% w/w 
anhydrous ZnC12 in glacial acetic acid and 98% acetyl chloride, as described by Chugaev. 
The structure of the colored end product is not certain although a mechanism in which the 
B-ring of the steroid nucleus is believed to open to produce an analog of Vitamin D has 
been suggested. 
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Only those compounds which exhibit optical activity and absorb electromagnetic 
radiation are detected by CD. Cholesterol and its esters meet these requirements but have a 
spectral maximum at 200nm. To simplify the measurement a color induction reaction is 
necessary for CD detection as it is with absorption detection. The reaction chosen must 
also produce a colored end product which meets the requirements of a chiral carbon with a 
chromophore in close proximity to facilitate CD detection. The Chugaev reaction produces 
such an end product. The Trinder reaction could not be used with CD detection since the 
colored quinoneimine end product is not optic,ally active and therefore not detected. 
CD detectors measure the difference bet~een the ab~orbances, of the two circularly 
polarized components of linearly polarized'light, as a function of wavelength (21). CD 
detection is more selective than absorbance and only CD-active compounds are potential 
interferences. The Chugaev reagent reacts with other steroids but because serum levels are 
too low and each steroid has a unique CD, spectrum they do not interfere (22). The CD 
spectrum is not affected by turbid specimens in the same way as an absorbance spectrum 
since scattering of the coincident beams, canc~ls when left and right absorbances are 
subtracted. 
A step by step procedure was followed for each serum sample undergoing the 
Chugaev reaction. A 50mL aliquot of serum was placed in a lOmL vial and 2mL of the 
zinc reagent were added. Then lmL of acetyl chloride is carefully added to the mixture 
which is then capped and thoroughly shaken. The solution is incubated at 67° for 8 
minutes during which time a reddish-orange color develops. The mixture is cooled and 
lmL of chloroform is added. It is then transferred to microcentrifuge tubes, centrifuged for 
2 minutes and transferred to a quartz spectrophotometric cuvet. The CD spectrum is then 







Figure 7. CD spectrum of the colored end product of the color reaction between the 
Chu~aev reagent and an NMS cholesterol standard reference material. 
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The data set that_was measured using the Chugaev-CD procedure included 134 
serum samples. This data set consisted of sets of samples taken at random from the serum 
samples provided by laboratories (A) and (D).> Triglyceride data were not available for all 
of the 134 samples. 
Standard Materials 
' . 
The National Bureau of Standards (NSS) cholesterol standard reference material 
' ' ' 
' 
(SRM911a) in chloroform was reacted with the Chugaev reagent and the colored end 
product produced the CD spectrum shown in Figure 7. Oeterminations on a series of 
' ' ' 
dilutions of the standard were made, and the data obtained were used to prepare calibration 
curves at a number of wavelengths. Analogous spectra were obtained for reactions with 
serum cholesterol and with standard solutions of cholesterol fatty acid esters in chloroform, 
which suggests that the cholesterol is totally converted t~ the the acetate ester under 
Chugaev reaction conditions. 
Standard Reference Materials for Cholesterol_in Human Serum (Frozen) were 
obtained from NBS at three different concentrations as listed in Table 1. The NBS 
literature stated that the samples were donated by the Center for Disease Control (CDC) and 
that the TC measurements were made at NBS with nine separate vials of each being 
measured twice each. The Certificate of Analysis accompanying these standards reported 
that the NBS data for each compared very well with the ,CDC measurements which used ·a 
modified Abell-Kendal! method. Ten Determinations were made on each reference 
standard using the Chugaev-CD procedure_ and the· data obtained (shown in Table 1) 







COMPARISON OF DATA ON NBS 












Confirmation of the band assignments was obtained by two methods. The 
precipitating reagent, phosphotungstate-Mg, was added to precipitate the VLDL-C and the 
LDL-C fractions, according to the Sigma 353-2 procedure, leaving the HDL-C fraction. 
The spectrum obtained after precipitation is shown in Figure 8(c). Selective separation of 
the a-lipoprotein fraction, which is associated with HDL-C, on a heparin-agarose 
stationary phase according to the procedure developed by ISOLAB® was performed as the 
second confirmation method and resulted in spectra similar to that depicted in Figure 8( c). 
CHAPTERV 
RESULTS AND DISCUSSION 
As previously stated the data set f<;:>r CD detection consists of 134 serum samples. 
; 
The TC for each sample was determined and these data are presented in Table 2 along with 
the corresponding TC measurement from the independent laboratories (A) apd (D). It is 
recognized that the absence of comparative measurements of the same sample from all three 
laboratories detracts from the completeness of the analysis but we were unable to do this 
due to a lack of funds. Since both independent laboratory methods utilized the Trinder 
reaction with absorption in the visible region as the detection method it is deemed valid to 
combine these data into one set i!l further analyses. 
It is possible to directly measure the HDL-C and the combined (VLDL+LDL)-C 
fractions separately due to the selectivity of the CD detector. This can be accomplished in a 
single experiment which does not require a precipitation step. Figure 8 shows typical 
spectra for: (a) total serum cholesterol in all its forms; (b) the (VLDL+LDL)-C fraction, this 
spectrum was obtained by subtracting the spectrum for HDL-C from the TC spectrum; and 
(c) the HDL-C fraction which was measured ·after the previously described precipitation 
reaction. From these spectra it can be seen that measurement at 525nm leads to direct 
detection of the (VLDL+LDL)-C fraction since the HDL-C fraction doe& not contribute to 
the band at this point. The HDL-C fraction is determined by measurement at either 475nm 
or 390nm or both. It is considered that the most precise numbers for HDL-C result when 
the calibration is based on the difference between the two, which avoids problems 


























Figure 8. CD spectra for (a) total serum cholesterol; (b) the (VLDL+LDL)-C fraction, 
equal to (a) minus (c); (c) the HDL-C fraction after the addition of 




TOTAL CHOLESTEROL DATA FROM 
(A), (D) AND .CD LABORATORIES 
Patient LaQoratory (A) · Laboratory (D) CD Laboratory 
UIM/001 . 258.0 271.9 
UIM/002 264.0 290.0 
UIM/003 229.0 185.8 
UIM/004 221.0 212.3 
UIM/005 211.0 225.1 
UIM/006 281.0 290.9 
UIM/007 203.7 195.2 
UIM/008 219.6 204.2 
UIM/009 159.5 ' 157.3 
UIM/010 255.0 ~. 259.8 
UIM/011 293.0 278.4 
UIM/012 203.0 214.3 
UIM/013 185.0 170.7 
UIM/014 168.0 167.3 
UIM/015 231.2 226.9 
UIM/016 233.0 239.5 
UIM/017 309.t 264.4 
UIM/018 294.0 268.0 
UIM/019 220.0 237.1 
UIM/020 227.0 256.1 
UIM/021 192.0 197.4 
UIM/022 . 134.0 146.2 
UIM/023 .166.0. 172.4 
UIM/024 166.0 182.6 
UIM/025 '254.0 273.1 
UIM/026 245.0 244.9 
UIM/027 179.0 177.9 
UIM/028 188'.0 183.5 
UIM/029 188.0 208.9 
UIM/030 214.0 ' 219.4 
UIM/031 219.0 . 218.3 
UIM/032 194.0 198.8 
UIM/033 127.0 132.4 
UIM/034 291.0 335.0 
UIM/035 252.0 232.9 
UIM/036 163.0 184.2 
UIM/037 189.0 222.2 
UIM/038 232.0 243~5 
UIM/039 192.0 193.5 
UIM/040. 114.0 138.0 
UIM/041 96.0 114.0 
UIM/042 208.0 231.0 
UIM/043 200.0 196.0 
UIMJQ44. 249.0 227.0 
UIM/045 ,• 197.0 198.0 
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TABLE 2 (Continued) 
Patient Laboratory (A) Laboratory (D) CD Laboratory 
LHM/046 313.0 336.5 323.2 
LHM/047 153.0 154.5 191.3 
LHM/048 177.0 186.3 219.7 
LHM/049 192.0 213.8 234.5 
LHM/050 258.0 251.5 283.7 
LHM/051 290.0 320.3 
LHM/052 273.0 314.3 
LHM/053 229.0 262.0 
LHM/054 223.9 234.9 
LHM/055 238.3 249.3 
LHM/056 189.6 195.2 
LHM/057 306.2 286.4 
LHM/058 314.7 325.0 
LHM/059 305.7 300.9 
LHM/060 260.4 254.5 
LHM/061 319.2 321.4 
LHM/062 276.1 263.0 
LHM/063 245.0 279.0 
LHM/064 287.5 321.3 
LHM/065 291.8 332.1 
LHM/066 252.0 278.7 
LHM/067 254.9 253.5 
LHM/068 386.5 369.5 
LHM/069 274.3 301.6 
LHM/070 257.0 275.5 
LHM/071 268.4 289.0 
LHM/072 159.7 171.7 
LHM/073 149.0 151.5 170.5 
LHM/074 101.0 112.4 173.1 
LHM/075 186.0 205.2 220.0 
LHM/076 144.0 151.0 177.0 
LHM/077 117.0 124.1 160.4 
LHM/078 223.0 221.9 295.4 
LHM/079 202.0 212.3 239.8 
LHM/080 183.0 200.2 
LHM/081 205.0 264.5 
LHM/082 213.0 248.3 
LHM/083 245.0 257.0 
LHM/084 219.0 239.3 
LHM/085 257.3 251.7 
LHM/086 265.3 296.5 
LHM/087 242.2 233.5 
















































TABLE 2 (Continued) 





















































































these subfractions ru;e combined to give the TC value. It is not possible to discriminate 
between the VLDL-C and LDL-C fractions at t:Jlis time. 
Table 3 presents the data from the measurement of distribution between the various 
lipid fractions made using the Chugaev-CD reaction (CD) and the combined results of the 
enzymatic methods (A)(D). The VLDL data are those provided by the independent 
laboratories and were calculated as 20% of the triglyceride. This data set is composed of 
99 serum samples. 
The attractiveness of enzymatic processes for serum cholesterol measurement is due 
to the selectivity of enzymes as reagents. Tbe detection method of absorbance, however, is 
not selective and has many potential sources of interference. In comparison the 
chromogenic Chugaev-CD procedure utilizes a reagent selective for steroids and full 
spectrum CD detection which is selective enough to discriminate not only among these 
steroids, but also between the high density and combined low density lipoprotein 
cholesterol subfractions as well. There are apparently no interferences with this detection 
method. 
No evidence was found that s"uggested that the choice of heparin or EDTA as the 
anticoagulating agent, by either independent laboratory, affected the results from CD 
detection. Within the Chugaev-CD data set the observed coefficient of variation for 
(VLDL+LDL)-C was ±2.3%. For HDL-C the imprecision was calculated using 390 and 
475nm difference data and was found to be ±6.3% CV~ The ±2.3% CV observed for the 
(VLDL+LDL)-C fraction is well within the recommended range for TC of ±3% CV that 
was proposed by the LSP for 1992. An improvement over the figures quoted in the 
introduction is shown using the CD method for imprecisions in HDL-C measurements. 
The LSP February 1990 (23) report figures include data from laboratories using both the 
(A) and (D) procedures and these figures are taken to be typical of what might be expected 
from the two independent laboratories contributing to this study. 
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TABLE3 
TOTAL CHOLES1EROL AND LIPID PROFILES 
FROM CD AND (A)+(D) LABORATORIES 
Pauent TC-(CD) LDL-(CD). HDL-(CD) VLDL-(A)(D) TC-(A)(D) LDL-(A)(D) HDL-(A)(D) 
SS001 273 174 57 43 254 148 63 
SS002 245 176 36 33 245 159 53 
SS003 191 134 40 17 179 117 45 
SS004 184 . 127 24 33 188 102 53 
SS005 209 113 74 22 188 
SS006 219 84 47 88 214 
SS007 178 126 26 25 '214 146 48 
SS008 199 137 38 24 194. 
SS009 132 97 22 14 127 
SSOlO 197 133. 42 22 192 129 41 
SS011 172 127 24 22 166 104 40 
SS012 268 162 .. 61 45 i>4 193 56 
SS013 183 127 39 17 166 86 63 
SS014 410 66 
SS015 260 176 64 . 20 255 176 59 
SS016 278 167 . 72 40 293 198 55 
SS017 214 139 52 23 203 140 40 
SS018 171 86 58 27 185 115 43 
SS019 167 103 44 20 168 94 54 
SS020 186 114 44 27 229 140 62 
SS021 212 142 42 28 221 140 53 
SS022 225 170 28 27 211 139 45 
SS023 291 184 39 68 281 183 30 
SS024 272 194 57 21 258 194 43 
SS025 290 213 57 . 21 !264 200 43 
SS026 101 65 17 19 106 
SS027 221 .160 39 22 206 
SS028 205 156 31 17 182 
SS029 256 171 34 52 229 
SS030 335 196 47 92 291 
SS031 233 155 47 31 252 
SS032 184 144 26 15 163 
SS033 222 122 38 62 189 
SS034 244 160 40 43 232 
SS035 194 148 31 14 192 
SS036 138 100 27 11 114 
SS037 114 76 26 11 96 
SS038 231 136 61 34 208 
SS039 196 152 26 18 200 
SS040 227 181 26 21 249 
SS041 197 140 40. 16 197 
SS042 235 189 28 18 224 144 62 
SS043 249 180 38 32 238 171 35 
SS044 195 152 30 13 190 136 40 
SS045 286 250 21 16 306 233 57 
SS046 325 237 52 36 315 229 50 
SS047 301 227 50 24 306 230 52 
SS048 254 198 37 20 260 181 60 
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TABLE 3 (Continued) 
Patient TC-(CD) LDL-(CD) HDL-(CD) VLDL-(A)(D) TC-(A)(D) LDL-(A)(D) HDL-(A)(D) 
SS049 321 43 319 44 
SS050 263 183 45 35 276 187 54 
SS051 279 198 61 20 245 166 59 
SS052 312 200 69 43 288 206 38 
SS053 332 212 57 63 292 195 34 
SS054 279 210 46. 22 252 165 65 
SS055 254 207 36 11 255 190 99 
SS056. 370 244 63 62 386 291 33 
SS057 302 207 56 39 274 203 33 
SS058 276 203 28 44. 257 169 44 
SS059 289 197 37 55 268 183 31 
SS060 172 100 30 48 160. . 115 36 
SS061 252 139 50 . 63 257 149 46 
SS062 296 141 64 91 265 
SS063 234 163 45 25 . 242 163 54 
SS064 255 130 58 62 270 167 41 
SS065 302 200 71 31 293 221 41 
SS066 259 182 42 34 246 176 36 
SS067 268 207 42 18 253 182 53 
SS068 284 218 44 22 242 173 48 
SS069 248 170 28 50 225 127 48 
SS070 214 146 43 25 199 131 43 
SS071 260 177 42 42 247 162 43 
SS072 211 161 34 15 186 134 37 
SS073 209 163 34 13 231 155 63 
SS074 280 209 40 31 274 214 30 
SS075 278 215 43 20 293 214 59 
SS076 238 178 ' 37 23 257 196 38 
SS077 252 173 42 37 256 172 47 
SS078 258 190 50 28 252 . 178 46 
SS079 286 27 
SS080 258 200 24 35 265 191 39 
SS081 204 152 38 14 197 117 66 
SS082 343 225 87 31 346 252 63 
SS083 271 187 51 33 271 190 48 
SS084 309 233 57 19 294 199 77 
SS085 . 300 172 57 71 282 174 37 
SS086 • 213 159 40 13 223 145 65 
SS087 208 146 42 20 226 135 71 
SS088 233 166 46 . 21 235 172 42 
SS089 276 195 59 22 267 191 55 
SS090 293 214 42 37 274 202 35-
SS091 318 248 47 23 309 216 69 
SS092 261 179 46 36 265 140 89 
SS093 215 167 26 22 231 153 56 
SS094 253 195 44 14 264 174 76 
SS095 218 143 31 45 220 133 42 
SS096 229 156 46 27 211 142 42 
SS097 220 155 45 20 202 149 33 
SS098 281 177 53 51 234 126 58 
SS099 196 141 42 13 184 126 45 
35 
The excellent precision with which the direct measurement of the combined low 
density lipid cholesterol level is made is-co11sidered to be the most significant result of this 
research. Fo:r purposes of monitoring LDL-C levels in reduction therapy, it seems 
unfortunate that information on the LDL-C fraction,can not be separated from that for the 
VLDL-C fraction, yet th~ ISOLAB® procedure has the same problem since both fractions 
coelute from the heparin-agarose stationary phase combined 'as the b-lipoprotein fraction. 
The Chugaev-CD procedure introduced here' is more precise in the measurement of HDL-C 
than the Trinder-absorption procedure and offers direct determ,ination of the combined low 
density fraction, therefore it is considered superior to these conventional commercial 
methods. 
Specific descriptipns of the interrelationships that exist among the three data sets 
which comprise this study are the emphasis of ,the remainder of this section. Figure 9 
shows excellent correlation between the TC data from the Trinder (measured values) and 
the Chugaev (calculated values) methods. The correlation slope is 0.918 and the y-
intercept is -25.9mg/dL. Both the (A) and (D) procedures are clinically approved and both 
use the same reaction, therefore it is considered valid to combine both sets of TC data into 
one group. It is clearly evident that the Chugaev~CD method for Jbe measurement of TC is 
valid. 
Comparisons between the commercial enzymatic and Chugaev-CD methods are 
limited to HDL-C and (VLDL+LDL)-C vs. TC data since no new method to measure 
VLDL-C was found. Data for these subfractions are plotted as a function of TC in Figure 
10 for (A), in Figure 11 for (D) and in Figure 12 for Chugaev-CD. Separate correlations 
for VLDL-C and LDL-C data are included in Figures 10 and 11. For the (A) and (D) data 
' ' ' 
' ' 
sets correlations are the same and, with the exception of HDL-C, all are linearly dependent 
on TC. All of the HDL-C data measured by the enzymatic processes can be fitted by the 
value range of 50±10mg/dL for the whole concentration range of TC. The imprecision in 
HDL-C measurements are propagated into the LDL-C values since they are calculated using 
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the HDL-C measurement. The non-zero intercept of -50mg/dL and the correlation slope of 
almost 1.0 for plots of (VLDL+LDL)-C vs. TC for both data sets make the carry over of 
error obvious. The plot of (VLDL+LDL)~C vs.TC becomes a plot of TC minus a constant 
vs. TC for all practical purposes, given that a common value of 50mg/dL can be used to fit 
all HDL-Cdata measured enzyn1atically. Fbr LDL-C calculated separate from VLDL-C the 
intercept is again about 50rhg/dL,when plotted against TC, with a slope reduced to around 
0.85 due to the linear dependence of VLDL.:.C with TC. It appears that LDL-C values can 
be estimated by assuming a constant value for HDL-C as accurately as they can be 
calculated using measured HDL-C values ... 
Determination~ made using the CD method gave excellent correlations for both 
(VLDL+LDL)-C and HDL-C as a funtion of TC, Figure 12. Slopes correspond with 
figures that, based upon ultracentrifugation data (24), are considered to be reasonable 
distributions of total cholesterol among the various lipid fractions. The figures showed 
(VLDL+LDL)-C to be approximately 85% of TC and HDL-C the remaining 15%. Using 
VLDL-C data from the TGL meas1.:1rements to separate the low density fractions in the CD 
measurements resulted in a LDL-C vs. TC plot which is linear with a y-intercept of4mg/dL 
) ' ' 
' ' 
and a (LDL-C)/TC slope of about 0.68, Figure 12. It seems logical that the excellent 
precision with which the combined low density fraction can be determined could allow this 
measurement to be applied to LDL-C reduction ~erapies especially considering that VLDL-
C is only a small part of this measurement. A proposal was included in the LSP report (6) 
that defined ris~ categories in terms <?f LDL-C levels rather than on TC. Table 4 
summarizes the risk categories. 
TABLE4 















The ranges are based on the assumption that LDL-C is about 66% of the total 
cholesterol, on the average, which is basically what is shown for the variation of LDL-C 
with TC using the CD procedure. 
Considerable improvement in the precision of HDL-C determinations using the 
Trinder reaction are required .if the LSP recommendations are to be met. A good alternative 
would be to directly measur:e the (VLDL+LDL)-C using the Chugaev-CD procedure and 
redefine the risk assessment ranges at 8?% of the cut-off values for TC. This would 
eliminate any errors in the assumption that everyone, regardless of physical condition, has 
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Figure 9. Total Cholesterol (CD) vs. Total Cholesterol (A) and (D). Least 
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Figure 10. TC vs. HDL-C, VLDL-C, LDL-C, and (VLDL+LDL)-C for 
Laboratory (A). Correlation equations are: 
(a) y = 44.5 + 0.002x (R2 = 0.004); 
(b) y = -10.5 + 0.16x (R2 = 0.1~0); 
(c) y = -33.4 + 0.82 x (R2 = 0.854); and 












Tota~ Cholesterol (mg/dL) 
Figure 11. TC vs. HDL-C (a), VLDL-C (b), LDL-C (c), and 
(VLDL+LJ)L)-C (d) for Laboratory (D). 
CorrelatiQn equations are: 
(a) y = 51.6 + 0.002x (R2=0.0); 
(b) y = -2.4 + 0.13x (R2=0.247); 
(c) y = -49.9 + 0.87x (R2=0.93); and 
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Figure 12. TCvs. (VLDL+LDL)-C, HDL-C, VLDL-C, LDL-C, and for 
CD Laboratory. , Correlation equations are: 
(a) y = -3.594 + 0.8432x (R = 0,9702); 
(b) y = 3.58 + 0.157x (R = 0.5998); 
(c) y = -9.203 + 0.1582x (R= 0.4568); and 
(d) y = 5.906 + 0.6826x (R= 0.865) respectively. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
It was the goal of this project to develoi> a method to determine cholesterol levels 
which would allow direct determination of high, low and very low density fractions of 
serum cholesterol. Although this goal was not completely realized the method developed 
did make it possible to determine HDL-C and the combined VLDL-C and LDL-C fractions 
directly with a significant increase in precision over currently used enzymatic methods. 
The two enzymatic methods and the CD detection method all show good 
correspondence among the TC valu~s deterinined. With the exception of the (A) and (D) 
determinations for the HDL-C fraction all lipid distributions exhibited linear dependence on 
TC. Measurements of HDL-C made by the commercial enzymatic methods were 
comparable. The existence of a basic systematic error in determinations of HDL-C made 
' ' 
using these conventional methods is a logical assumption. The necessity of a precipitation 
reaction is one possible cause of this error, since precipitation reactions are difficult to 
reproduce consistently. Many other factors which could be contributing to the error have 
been considered (5), one of which is the inconsistencies resulting from the use of different 
precipitating agents. 
It was anticipated that larger errors would result, if methods of determination which 
had produced large relative inaccuracies (CV>±5%) for the measurement of TC, were also 
used for the determination of the significantly smaller amounts of HDL-C. With the added 
difficulty of extracting the low density fractions (5), it was certainly expected that the HDL-
C fraction would involve greater experimental error in its measurement than in the 
measurement of TC. Even with this expectation the correlation of zero was a surprising 
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result. It was expected that the ratio, TC/HDL-C, lacked diagnostic value due to the errors 
associated with the HDL-C measurement. It is increasingly apparent that a more accurate 
and reliable method for the direct determination of HDL-C or LDL-C is a necessity. 
The newly developed method combining chromogenic reaction with CD detection 
exhibits good linearity for correlations between TC measurements and determinations of 
both HDL-C and (VLDL+LDL)-C. The differences between CD correlations and the (A) 
and (D) correlations apparently must be due to the errors in the HDL-C measurements 
obtained from the enzymatic methods since all three methods are in close agreement for TC 
measurements. It is conceivable that the significant improvement in quality of the HDL-C 
measurements when the CD detection method is used results from the lack of a precipitation 
step in these determinations and the fact that CD-inactive substances,such as hemolyzed red 
blood cells, and high triglyceride levels do not interfere with CD detection. 
Reconsideration of a second diagnostic parameter, based on the proportion of HDL-'C in 
the TC, may be justified given this improvement in HDL-C data. The precision in 
(VLDL+LDL)-C measurements have also been greatly improved which may lead to this 
quantity being a more reliable parameter for reduction therapy monitoring. 
It can be concluded from this study that the present NCEP recommendation that 
patient risk be evaluated only upon measurements of total cholesterol is justified and that as 
long as measurement of HDL-C is unreliable and inaccurate it has Jittle diagnostic value. 
The CD detection method discussed here holds promise for accurate measurement of lipid 
distributions and, therefore should be pursued as a tool for the health industry. 
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